Pub Date : 2025-12-01DOI: 10.1016/j.inpm.2025.100718
Christopher L. Robinson , Milan P. Stojanovic , Zachary L. McCormick
{"title":"Regenerative medicine: Are we at a crossroads for interventional pain medicine or just another phase?","authors":"Christopher L. Robinson , Milan P. Stojanovic , Zachary L. McCormick","doi":"10.1016/j.inpm.2025.100718","DOIUrl":"10.1016/j.inpm.2025.100718","url":null,"abstract":"","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 4","pages":"Article 100718"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145693700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.inpm.2025.100716
Fabricio Andres Lasso Andrade , Gabriel Gaviria Suarez , Alejandro Fernández Escobar , Roberto Carlo Rivera Díaz , Denny Marcela Achicanoy Puchana , Javier Esteban Toro-López
Introduction
The sphenopalatine ganglion (SPG) is a key structure in the pathophysiology of various craniofacial pain syndromes with autonomic manifestations, integrating parasympathetic, sympathetic, and trigeminal fibers within the trigemino-autonomic reflex. Modulation of these pathways through nerve block or radiofrequency has shown effectiveness in managing pain and associated autonomic symptoms. However, no previous reports have described the use of a suprazygomatic approach for thermal radiofrequency of the SPG.
Case report
We present the case of a 70-year-old man with a one-year history of left-sided persistent idiopathic facial pain (PFPS), characterized by paroxysmal exacerbations in the V1–V2 territories, epiphora, and nasal congestion, without evidence of structural lesions or classical neuropathy. After unsuccessful treatment with carbamazepine and a diagnostic Gasserian ganglion block, a suprazygomatic SPG block with 1 % lidocaine was performed, achieving 80 % pain relief lasting four weeks. Upon recurrence of pain, fluoroscopy-guided thermal radiofrequency (TRF) of the SPG (80 °C, 60 s) was conducted, resulting in sustained improvement (NRS 1/10) at six months, with no sensory deficits or adverse effects. This case demonstrated that the suprazygomatic approach provides a safe route to access the pterygopalatine fossa.
Conclusion
Thermal radiofrequency of the SPG via the suprazygomatic approach may represent an effective and safe alternative for treating persistent idiopathic facial pain with autonomic features.
{"title":"Thermal radiofrequency of the sphenopalatine ganglion in persistent idiopathic facial pain using a suprazygomatic approach: Case report","authors":"Fabricio Andres Lasso Andrade , Gabriel Gaviria Suarez , Alejandro Fernández Escobar , Roberto Carlo Rivera Díaz , Denny Marcela Achicanoy Puchana , Javier Esteban Toro-López","doi":"10.1016/j.inpm.2025.100716","DOIUrl":"10.1016/j.inpm.2025.100716","url":null,"abstract":"<div><h3>Introduction</h3><div>The sphenopalatine ganglion (SPG) is a key structure in the pathophysiology of various craniofacial pain syndromes with autonomic manifestations, integrating parasympathetic, sympathetic, and trigeminal fibers within the trigemino-autonomic reflex. Modulation of these pathways through nerve block or radiofrequency has shown effectiveness in managing pain and associated autonomic symptoms. However, no previous reports have described the use of a suprazygomatic approach for thermal radiofrequency of the SPG.</div></div><div><h3>Case report</h3><div>We present the case of a 70-year-old man with a one-year history of left-sided persistent idiopathic facial pain (PFPS), characterized by paroxysmal exacerbations in the V1–V2 territories, epiphora, and nasal congestion, without evidence of structural lesions or classical neuropathy. After unsuccessful treatment with carbamazepine and a diagnostic Gasserian ganglion block, a suprazygomatic SPG block with 1 % lidocaine was performed, achieving 80 % pain relief lasting four weeks. Upon recurrence of pain, fluoroscopy-guided thermal radiofrequency (TRF) of the SPG (80 °C, 60 s) was conducted, resulting in sustained improvement (NRS 1/10) at six months, with no sensory deficits or adverse effects. This case demonstrated that the suprazygomatic approach provides a safe route to access the pterygopalatine fossa.</div></div><div><h3>Conclusion</h3><div>Thermal radiofrequency of the SPG via the suprazygomatic approach may represent an effective and safe alternative for treating persistent idiopathic facial pain with autonomic features.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 4","pages":"Article 100716"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145693588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.inpm.2025.100711
Napatpaphan Kanjanapanang , Hasan Sen , Amanda N. Cooper , Audrey Adler , Akbar Nabi , Blake Dickenson , William Tang , Chase Young , Taylor Burnham , Alexandra E. Fogarty , Allison Glinka Przybysz , Aaron M. Conger , Zachary L. McCormick
Background
Lumbar medial branch radiofrequency ablation (LMBRFA) is an established treatment for chronic lumbar zygapophysial (facet) joint pain. Three-tined radiofrequency technology may simplify the procedure compared to conventional techniques, but long-term outcomes require further investigation.
Objectives
To assess long-term outcomes of three-tined LMBRFA utilizing a perpendicular approach.
Methods
This study reviewed electronic medical records of patients who underwent three-tined LMBRFA from 2022 to 2024. Clinical outcomes were assessed at ≥6 months post-procedure via standardized telephone survey, including numerical rating scale (NRS) pain scores, patient global impression of change (PGIC), and opioid utilization. The primary outcome was the proportion of patients achieving ≥50 % NRS pain reduction. Secondary outcomes included PGIC scores ≥6 (“much improved” or better) and changes in opioid use. Poisson regression evaluated select predictors of treatment response.
Results
Outcomes were collected from 71 patients at a mean follow-up of 12.5 ± 2.4 months. The primary outcome was achieved by 43.7 % (95 %CI: 32.8–55.2) of patients at mean follow-up, with higher success rates at 6–12 months (51.7 %) compared to 12–18 months (38.1 %; p = 0.332). At average follow-up, 53.5 % (95 %CI: 42.0–64.6) of patients reported PGIC scores ≥6, while opioid analgesic use was significantly reduced from baseline (75 % opioid cessation rate among baseline opioid users). Advanced age, repeat LMBRFA, and shorter follow-up were associated with a greater likelihood of treatment success.
Conclusion
In this cohort, approximately half of patients selected for three-tined perpendicular LMBRFA by guideline-concordant diagnostic blocks went on to experience ≥50 % pain relief for up to 12 months. Opioid analgesic use was significantly reduced compared to baseline.
{"title":"The effectiveness of lumbar medial branch radiofrequency ablation using a three-tined electrode: A real-world cross-sectional cohort study","authors":"Napatpaphan Kanjanapanang , Hasan Sen , Amanda N. Cooper , Audrey Adler , Akbar Nabi , Blake Dickenson , William Tang , Chase Young , Taylor Burnham , Alexandra E. Fogarty , Allison Glinka Przybysz , Aaron M. Conger , Zachary L. McCormick","doi":"10.1016/j.inpm.2025.100711","DOIUrl":"10.1016/j.inpm.2025.100711","url":null,"abstract":"<div><h3>Background</h3><div>Lumbar medial branch radiofrequency ablation (LMBRFA) is an established treatment for chronic lumbar zygapophysial (facet) joint pain. Three-tined radiofrequency technology may simplify the procedure compared to conventional techniques, but long-term outcomes require further investigation.</div></div><div><h3>Objectives</h3><div>To assess long-term outcomes of three-tined LMBRFA utilizing a perpendicular approach.</div></div><div><h3>Methods</h3><div>This study reviewed electronic medical records of patients who underwent three-tined LMBRFA from 2022 to 2024. Clinical outcomes were assessed at ≥6 months post-procedure via standardized telephone survey, including numerical rating scale (NRS) pain scores, patient global impression of change (PGIC), and opioid utilization. The primary outcome was the proportion of patients achieving ≥50 % NRS pain reduction. Secondary outcomes included PGIC scores ≥6 (“much improved” or better) and changes in opioid use. Poisson regression evaluated select predictors of treatment response.</div></div><div><h3>Results</h3><div>Outcomes were collected from 71 patients at a mean follow-up of 12.5 ± 2.4 months. The primary outcome was achieved by 43.7 % (95 %CI: 32.8–55.2) of patients at mean follow-up, with higher success rates at 6–12 months (51.7 %) compared to 12–18 months (38.1 %; <em>p</em> = 0.332). At average follow-up, 53.5 % (95 %CI: 42.0–64.6) of patients reported PGIC scores ≥6, while opioid analgesic use was significantly reduced from baseline (75 % opioid cessation rate among baseline opioid users). Advanced age, repeat LMBRFA, and shorter follow-up were associated with a greater likelihood of treatment success.</div></div><div><h3>Conclusion</h3><div>In this cohort, approximately half of patients selected for three-tined perpendicular LMBRFA by guideline-concordant diagnostic blocks went on to experience ≥50 % pain relief for up to 12 months. Opioid analgesic use was significantly reduced compared to baseline.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 4","pages":"Article 100711"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145623903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anterior cutaneous nerve entrapment syndrome (ACNES) is a neuropathic pain condition characterized by irritation or compression of abdominal wall intercostal nerve branches called the anterior cutaneous nerves. Peripheral nerve stimulation (PNS) has become an effective treatment option for painful sensory neuropathic conditions, including mononeuropathies and nerve entrapment syndromes. This report describes a successful case of using temporary PNS to treat ACNES and reviews the available literature on the use of PNS for the treatment of ACNES.
Case presentation
A 38-year-old female with a complex abdominal medical and surgical history presented to the pain medicine clinic for intractable burning pain and pressure in the left upper quadrant of the periumbilical region. Given the patient's clinical history and the nature of her presenting symptoms, ACNES was considered as a potential diagnosis. The diagnosis was confirmed through a series of successful diagnostic rectus sheath nerve blocks. A two-month temporary peripheral nerve stimulator trial targeting the left anterior cutaneous nerve was completed, and it resulted in 80 % pain reduction at 3 and 6-month follow-up evaluations, with returning pain at the 8-month assessment.
Conclusion
Chronic abdominal pain in patients with a complex history of abdominal surgery should alert pain specialists to consider the possibility of an ACNES diagnosis. Current evidence supporting PNS for ACNES is limited to a small number of case reports showing successful treatment; however, larger-scale and more robust studies are needed to determine the effectiveness and safety of this method. This study contributes to the existing body of literature, highlighting that PNS may serve as a valuable treatment option for individuals with chronic abdominal wall pain secondary to ACNES whose pain is refractory to conservative management strategies.
{"title":"Peripheral nerve stimulation for the treatment of anterior cutaneous nerve entrapment syndrome: A case report and literature review","authors":"Royce Copeland , Yacoub Khatab , Ravinderjit Singh , Emanuel N. Husu","doi":"10.1016/j.inpm.2025.100653","DOIUrl":"10.1016/j.inpm.2025.100653","url":null,"abstract":"<div><h3>Background</h3><div>Anterior cutaneous nerve entrapment syndrome (ACNES) is a neuropathic pain condition characterized by irritation or compression of abdominal wall intercostal nerve branches called the anterior cutaneous nerves. Peripheral nerve stimulation (PNS) has become an effective treatment option for painful sensory neuropathic conditions, including mononeuropathies and nerve entrapment syndromes. This report describes a successful case of using temporary PNS to treat ACNES and reviews the available literature on the use of PNS for the treatment of ACNES.</div></div><div><h3>Case presentation</h3><div>A 38-year-old female with a complex abdominal medical and surgical history presented to the pain medicine clinic for intractable burning pain and pressure in the left upper quadrant of the periumbilical region. Given the patient's clinical history and the nature of her presenting symptoms, ACNES was considered as a potential diagnosis. The diagnosis was confirmed through a series of successful diagnostic rectus sheath nerve blocks. A two-month temporary peripheral nerve stimulator trial targeting the left anterior cutaneous nerve was completed, and it resulted in 80 % pain reduction at 3 and 6-month follow-up evaluations, with returning pain at the 8-month assessment.</div></div><div><h3>Conclusion</h3><div>Chronic abdominal pain in patients with a complex history of abdominal surgery should alert pain specialists to consider the possibility of an ACNES diagnosis. Current evidence supporting PNS for ACNES is limited to a small number of case reports showing successful treatment; however, larger-scale and more robust studies are needed to determine the effectiveness and safety of this method. This study contributes to the existing body of literature, highlighting that PNS may serve as a valuable treatment option for individuals with chronic abdominal wall pain secondary to ACNES whose pain is refractory to conservative management strategies.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 4","pages":"Article 100653"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145624041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.inpm.2025.100708
John Tran , Alicia J. Chung , Ian bell , Brent Lanting , Zachary L. McCormick , Eldon Loh
Background
Sensory afferents supplying subchondral bone could mediate pain from the knee joint. Intrinsic innervation originates externally and follows blood vessels through nutrient foramina. Therefore, targeting the intrinsic innervation of subchondral bone can be achieved by capturing extrinsic innervation prior to their entry into the nutrient foramina. Understanding of extrinsic innervation of the knee joint as well as the distribution of the epiphyseal nutrient foramina are important. Currently, the distribution of nutrient foramina has not been analyzed. The objective of this osteological study was to quantify the distribution of nutrient foramina in the distal femur to inform knee joint denervation strategies.
Methods
A convenience sample of 19 bony femurs was used in this study. The distal end of each specimen was photographed to obtain standardized lateral, medial, and anterior views. The location of nutrient foramina was documented. Each photograph was imported into ImageJ and the distribution of nutrient foramina was quantified.
Results
Location of epiphyseal nutrient foramina was variable on distal femur. Laterally, distribution of nutrient foramina showed percentages of 11.5 %, 44.7 %, 36.5 %, and 7.3 % in the first, second, third, and fourth quadrants, respectively. Distribution on the medial distal femur showed percentages of 12.4 %, 40.4 %, 35.5 %, and 11.5 % in the first, second, third, and fourth quadrants, respectively. Anteriorly, distribution showed a difference between the medial and lateral halves with percentages of 71.1 % and 28.9 %, respectively.
Conclusions
Epiphyseal nutrient foramina are important conduits that enable extrinsic innervation to enter and supply the subchondral bone. The location and distribution of the nutrient foramina of the distal femur reported in this study can be used to optimize nerve blocks and denervation techniques to manage chronic knee joint pain from osteoarthritis.
{"title":"Distribution of epiphyseal nutrient foramina in the distal femur: Implications for anterior knee joint denervation","authors":"John Tran , Alicia J. Chung , Ian bell , Brent Lanting , Zachary L. McCormick , Eldon Loh","doi":"10.1016/j.inpm.2025.100708","DOIUrl":"10.1016/j.inpm.2025.100708","url":null,"abstract":"<div><h3>Background</h3><div>Sensory afferents supplying subchondral bone could mediate pain from the knee joint. Intrinsic innervation originates externally and follows blood vessels through nutrient foramina. Therefore, targeting the intrinsic innervation of subchondral bone can be achieved by capturing extrinsic innervation prior to their entry into the nutrient foramina. Understanding of extrinsic innervation of the knee joint as well as the distribution of the epiphyseal nutrient foramina are important. Currently, the distribution of nutrient foramina has not been analyzed. The objective of this osteological study was to quantify the distribution of nutrient foramina in the distal femur to inform knee joint denervation strategies.</div></div><div><h3>Methods</h3><div>A convenience sample of 19 bony femurs was used in this study. The distal end of each specimen was photographed to obtain standardized lateral, medial, and anterior views. The location of nutrient foramina was documented. Each photograph was imported into ImageJ and the distribution of nutrient foramina was quantified.</div></div><div><h3>Results</h3><div>Location of epiphyseal nutrient foramina was variable on distal femur. Laterally, distribution of nutrient foramina showed percentages of 11.5 %, 44.7 %, 36.5 %, and 7.3 % in the first, second, third, and fourth quadrants, respectively. Distribution on the medial distal femur showed percentages of 12.4 %, 40.4 %, 35.5 %, and 11.5 % in the first, second, third, and fourth quadrants, respectively. Anteriorly, distribution showed a difference between the medial and lateral halves with percentages of 71.1 % and 28.9 %, respectively.</div></div><div><h3>Conclusions</h3><div>Epiphyseal nutrient foramina are important conduits that enable extrinsic innervation to enter and supply the subchondral bone. The location and distribution of the nutrient foramina of the distal femur reported in this study can be used to optimize nerve blocks and denervation techniques to manage chronic knee joint pain from osteoarthritis.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 4","pages":"Article 100708"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145624045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.inpm.2025.100706
Logan F. Condon , Ryu Komatsu , Jiang Wu
Introduction
The sphenopalatine ganglion (SPG) drives the cranial autonomic symptoms associated with trigeminal autonomic cephalalgias, migraine, and trigeminal neuralgia. Infrazygomatic approach SPG block serves as the gold standard for both prognostic and therapeutic intervention for management of refractory headache with autonomic symptoms. However, this intervention often provides only short-term relief. Identification of novel interventions that provide more durable relief is imperative.
Case
An 84-year-old female with chronic headache featuring autonomic cranial symptoms that failed both medication and conservative intervention management. Patient responded well to infrazygomatic approach SPG block using combined cone beam CT and fluoroscopy guidance, however, experienced fading therapeutic response over the years. Subsequently, patient underwent neurocryoablation of the SPG, from which, satisfactory and sustained improvement of her headache pain was achieved at six month follow up.
Conclusion
This is the first case demonstrating the clinical feasibility and therapeutic outcomes of SPG neurocryoablation in treating refractory headaches.
{"title":"A case report: Infrazygomatic approach neurocryoablation of the sphenopalatine ganglion under cone beam computer tomography guidance in treating refractory headaches","authors":"Logan F. Condon , Ryu Komatsu , Jiang Wu","doi":"10.1016/j.inpm.2025.100706","DOIUrl":"10.1016/j.inpm.2025.100706","url":null,"abstract":"<div><h3>Introduction</h3><div>The sphenopalatine ganglion (SPG) drives the cranial autonomic symptoms associated with trigeminal autonomic cephalalgias, migraine, and trigeminal neuralgia. Infrazygomatic approach SPG block serves as the gold standard for both prognostic and therapeutic intervention for management of refractory headache with autonomic symptoms. However, this intervention often provides only short-term relief. Identification of novel interventions that provide more durable relief is imperative.</div></div><div><h3>Case</h3><div>An 84-year-old female with chronic headache featuring autonomic cranial symptoms that failed both medication and conservative intervention management. Patient responded well to infrazygomatic approach SPG block using combined cone beam CT and fluoroscopy guidance, however, experienced fading therapeutic response over the years. Subsequently, patient underwent neurocryoablation of the SPG, from which, satisfactory and sustained improvement of her headache pain was achieved at six month follow up.</div></div><div><h3>Conclusion</h3><div>This is the first case demonstrating the clinical feasibility and therapeutic outcomes of SPG neurocryoablation in treating refractory headaches.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 4","pages":"Article 100706"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145623901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.inpm.2025.100712
Patricia Zheng, Conor O'Neill
{"title":"Subject: Letters to the editor: Re: rates of lumbar vertebral body compression fracture after basivertebral nerve ablation: A retrospective study utilizing a large national database","authors":"Patricia Zheng, Conor O'Neill","doi":"10.1016/j.inpm.2025.100712","DOIUrl":"10.1016/j.inpm.2025.100712","url":null,"abstract":"","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 4","pages":"Article 100712"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145624044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.inpm.2025.100703
Harold Burke , Michael Liu , Salim M. Hayek
Introduction
Chronic Abdominal Pain (CAP) is a pervasive and challenging global health issue. In a 2023 United States National Health Interview Survey, CAP was present in almost 3 % of all respondents. Various interventional procedures, such as sympathetic nerve blocks (SNBs), thoracolumbar sympathetic ablations, and spinal cord stimulation (SCS), have shown mixed efficacy in managing CAP. This case series describes refractory CAP that is effectively managed with IDD after a treatment algorithm to first distinguish nociceptive pain from a centrally mediated process, but only when the AGA ROME IV criteria for CAP is met.
Methods
Four patients were identified in clinical practice as suitable candidates for an IDD for refractory, non-centrally mediated CAP. Two of the patients had constant CAP meeting the ROME IV AGA diagnostic criteria for CAP and therefore underwent a DDE-ultimately with findings suggestive of visceral or somatic pain given a >70 % reduction in pain after administration of the local anesthetic and confirmation of a sensory level change, but not after the administration of normal saline prior. (Tabe 1). All patients underwent a continuous intrathecal catheter trial, except for one patient with cystic fibrosis and unpredictable pancreatitis pain episodes, who had failed a spinal cord stimulator implant and proceeded straight to an IDDS implant.
Results
IDD effectively managed refractory CAP across these four cases, with implantation durations ranging from 1.5 to 10 years. All patients remained off systemic opioids and maintained complete functional independence-specifically their Activities of Daily Living (ADLs) as well as Instrumental ADLs.
Discussion
Effective management of CAP begins with a precise diagnosis that distinguishes between nociceptive and centrally mediated pain. Once centrally mediated pain is excluded, and provided patients did not experience sufficient analgesia with other less invasive interventions, targeted treatment for visceral/nociceptive pain with intrathecal drug delivery can be attempted. This case series highlights IDD as a promising alternative to other interventional therapies for refractory CAP, offering durable pain relief with potentially fewer complications.
慢性腹痛(CAP)是一个普遍和具有挑战性的全球健康问题。在2023年美国全国健康访谈调查中,几乎3%的受访者存在CAP。各种介入治疗方法,如交感神经阻滞(SNBs)、胸腰段交感神经消融和脊髓刺激(SCS),在治疗CAP方面显示出不同的疗效。本病例系列描述了在治疗算法首先区分伤害性疼痛和中枢介导过程后,用IDD有效治疗难治性CAP的难治性CAP,但只有在满足AGA ROME IV CAP标准的情况下。方法:在临床实践中,4例患者被确定为难治性非中枢介导性CAP的合适IDD候选人。其中2例患者的持续性CAP符合ROME IV AGA对CAP的诊断标准,因此接受了dde,最终发现提示内脏或躯体疼痛,在给予局麻药并确认感觉水平改变后疼痛减轻了70%,但在给予生理盐水后没有。(课程1)。所有患者都进行了连续的鞘内导管试验,除了一名患有囊性纤维化和不可预测的胰腺炎疼痛发作的患者,他在脊髓刺激器植入失败后直接进行了IDDS植入。结果4例患者中,sidd有效控制了难治性CAP,植入时间从1.5年到10年不等。所有患者都没有使用全身性阿片类药物,并保持了完全的功能独立性,特别是他们的日常生活活动(adl)和工具性adl。CAP的有效管理始于对伤害性疼痛和中枢介导性疼痛的精确诊断。一旦排除了中枢介导的疼痛,并且患者在其他侵入性较小的干预措施下没有获得足够的镇痛,可以尝试鞘内给药靶向治疗内脏/伤害性疼痛。本病例系列强调IDD作为难治性CAP的其他介入治疗的有希望的替代方法,提供持久的疼痛缓解,潜在的并发症更少。
{"title":"Intrathecal drug delivery for chronic abdominal pain: A case series","authors":"Harold Burke , Michael Liu , Salim M. Hayek","doi":"10.1016/j.inpm.2025.100703","DOIUrl":"10.1016/j.inpm.2025.100703","url":null,"abstract":"<div><h3>Introduction</h3><div>Chronic Abdominal Pain (CAP) is a pervasive and challenging global health issue. In a 2023 United States National Health Interview Survey, CAP was present in almost 3 % of all respondents. Various interventional procedures, such as sympathetic nerve blocks (SNBs), thoracolumbar sympathetic ablations, and spinal cord stimulation (SCS), have shown mixed efficacy in managing CAP. This case series describes refractory CAP that is effectively managed with IDD after a treatment algorithm to first distinguish nociceptive pain from a centrally mediated process, but only when the AGA ROME IV criteria for CAP is met.</div></div><div><h3>Methods</h3><div>Four patients were identified in clinical practice as suitable candidates for an IDD for refractory, non-centrally mediated CAP. Two of the patients had constant CAP meeting the ROME IV AGA diagnostic criteria for CAP and therefore underwent a DDE-ultimately with findings suggestive of visceral or somatic pain given a >70 % reduction in pain after administration of the local anesthetic and confirmation of a sensory level change, but not after the administration of normal saline prior. (Tabe 1). All patients underwent a continuous intrathecal catheter trial, except for one patient with cystic fibrosis and unpredictable pancreatitis pain episodes, who had failed a spinal cord stimulator implant and proceeded straight to an IDDS implant.</div></div><div><h3>Results</h3><div>IDD effectively managed refractory CAP across these four cases, with implantation durations ranging from 1.5 to 10 years. All patients remained off systemic opioids and maintained complete functional independence-specifically their Activities of Daily Living (ADLs) as well as Instrumental ADLs.</div></div><div><h3>Discussion</h3><div>Effective management of CAP begins with a precise diagnosis that distinguishes between nociceptive and centrally mediated pain. Once centrally mediated pain is excluded, and provided patients did not experience sufficient analgesia with other less invasive interventions, targeted treatment for visceral/nociceptive pain with intrathecal drug delivery can be attempted. This case series highlights IDD as a promising alternative to other interventional therapies for refractory CAP, offering durable pain relief with potentially fewer complications.</div></div>","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 4","pages":"Article 100703"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145693589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-01DOI: 10.1016/j.inpm.2025.100715
Hemant Kalia , Scott Pritzlaff , Konstantin Slavin
{"title":"Letter to the Editor: Intellectual conflicts of interest in spinal cord stimulation research - The gap between theoretical knowledge and clinical expertise","authors":"Hemant Kalia , Scott Pritzlaff , Konstantin Slavin","doi":"10.1016/j.inpm.2025.100715","DOIUrl":"10.1016/j.inpm.2025.100715","url":null,"abstract":"","PeriodicalId":100727,"journal":{"name":"Interventional Pain Medicine","volume":"4 4","pages":"Article 100715"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145693591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}